Previous close | 8.65 |
Open | 8.79 |
Bid | 8.52 x 100 |
Ask | 8.63 x 200 |
Day's range | 8.55 - 9.09 |
52-week range | 1.93 - 9.09 |
Volume | |
Avg. volume | 210,998 |
Market cap | 452.506M |
Beta (5Y monthly) | 0.90 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TScan Therapeutics (TCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Key Insights Significantly high institutional ownership implies TScan Therapeutics' stock price is sensitive to their...